McCormick & Co Inc/ US5797802064 /
2024-04-26 9:59:51 PM | Chg. +0.21 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
75.77USD | +0.28% | 37,969 Turnover: 2.88 mill. |
-Bid Size: - | -Ask Size: - | 20.33 bill.USD | 2.06% | 29.82 |
GlobeNewswire
04-25
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
GlobeNewswire
04-24
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO...
GlobeNewswire
04-24
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (AS...
GlobeNewswire
04-24
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of ...
GlobeNewswire
04-24
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
GlobeNewswire
04-24
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire
04-24
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASC...
GlobeNewswire
04-24
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B...
GlobeNewswire
04-22
Loans Reach Another All-Time High, Credit Quality Remains Solid; TrustCo Reports Net Income of $12.1...
GlobeNewswire
04-16
Douglas Dynamics Announces First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
03-20
SERB Pharmaceuticals grants exclusive license to M8 Pharmaceuticals, an Acino company, to bring Vora...
GlobeNewswire
02-21
Strong Capital Supports TrustCo’s Consistent Dividend; Annualized Payout of $1.44 per share